gip vs glp-1 The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Dual GLP-1/GIP Agonist | Tirzepatide

compounded tirzepatide at $249/month versus $1,000+ for Zepbound

Losing muscle mass compromises physical function and metabolic health

While some physicians are prescribing these medications for their approved uses of treating type 2 diabetes, obesity and obstructive sleep apnea, others are frequently making off-label prescriptions

Understanding its effects establishes the baseline against which all subsequent escalations are measured

Is triGLP the same as a prescription GLP-1 medication

As mentioned, albiglutide is no longer available, and thus, details on the HARMONY trial are not included in this clinical review